As of 2026-11-03, the Intrinsic Value of Aptose Biosciences Inc (APS.TO) is -20.21 CAD. This APS.TO valuation is based on the model Peter Lynch Fair Value. With the current market price of 2.40 CAD, the upside of Aptose Biosciences Inc is -942.20%.
Based on its market price of 2.40 CAD and our intrinsic valuation, Aptose Biosciences Inc (APS.TO) is overvalued by 942.20%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -20.21 - -20.21 | -20.21 | -942.20% |
| DDM - Stable | (253.16) - (894.20) | (573.68) | -24003.4% |
| DDM - Multi | (217.84) - (659.04) | (334.48) | -14036.5% |
| Market Cap (mil) | 2.99 |
| Beta | -0.49 |
| Outstanding shares (mil) | 1.25 |
| Enterprise Value (mil) | -7.28 |
| Market risk premium | 5.10% |
| Cost of Equity | 13.73% |
| Cost of Debt | 5.00% |
| WACC | 8.71% |